<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00923338</url>
  </required_header>
  <id_info>
    <org_study_id>09-006</org_study_id>
    <secondary_id>350012</secondary_id>
    <nct_id>NCT00923338</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug</brief_title>
  <acronym>VVP</acronym>
  <official_title>Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      This clinical trial will study the safety and effectiveness of the Biodesign Vesico-vaginal&#xD;
      fistula plug in the treatment of vesico-vaginal fistulas resulting from childbirth trauma.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fistula</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Vesico-vaginal Fistula</condition>
  <arm_group>
    <arm_group_label>Vesico-vaginal fistula plug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vesico-vaginal fistula plug</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgisis Biodesign (Vesico-vaginal fistula plug)</intervention_name>
    <description>Vesico-vaginal fistula plug</description>
    <arm_group_label>Vesico-vaginal fistula plug</arm_group_label>
    <other_name>SurgiSIS Biodesign</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has signed and dated the informed consent.&#xD;
&#xD;
          -  Patient is 18 years old; or is an emancipated minor as defined by Ugandan law or is&#xD;
             under 18 but has a parent/guardian who provides informed consent.&#xD;
&#xD;
          -  Patient agrees to follow-up schedule.&#xD;
&#xD;
          -  Patient presents with a leaking vesico-vaginal fistula, confirmed by exam, with no&#xD;
             signs of acute inflammation, no signs of active urinary tract infection that cannot be&#xD;
             controlled with a standard pre-operative course of antibiotics, no signs of vaginal&#xD;
             infection, or no signs of abscess.&#xD;
&#xD;
          -  Patient presents with a fistula of a size and in a location that may be reasonably&#xD;
             treated with the VVP device.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is not medically fit enough for surgery under general or spinal anesthesia.&#xD;
&#xD;
          -  Patient is a &quot;mature minor&quot; as defined by Ugandan law.&#xD;
&#xD;
          -  Patient is pregnant, breastfeeding or planning further pregnancy during the study&#xD;
             period.&#xD;
&#xD;
          -  Patient has physical allergies or cultural objections to the receipt of porcine&#xD;
             products.&#xD;
&#xD;
          -  Patient has an active sexually transmitted disease, is HIV-positive, or any other&#xD;
             active systemic infection that may interfere with healing.&#xD;
&#xD;
          -  Patient has spina bifida or other neural tube defect.&#xD;
&#xD;
          -  Patient has interstitial cystitis or other chronic pelvic pain syndrome.&#xD;
&#xD;
          -  Patient has signs of acute or chronic pelvic inflammation, active urinary tract&#xD;
             infection not responsive to antibiotic treatment, vaginal infection, or abscess of the&#xD;
             fistula tract.&#xD;
&#xD;
          -  Patient presents with clinically diagnosed sepsis (for whatever reason).&#xD;
&#xD;
          -  Patient has concomitant ureterovaginal fistula.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Musa Kayondo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mbarara University Teaching Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mbarara University Teaching Hospital</name>
      <address>
        <city>Mbarara</city>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>June 16, 2009</study_first_submitted>
  <study_first_submitted_qc>June 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2009</study_first_posted>
  <last_update_submitted>December 29, 2015</last_update_submitted>
  <last_update_submitted_qc>December 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fistula</keyword>
  <keyword>vesico-vaginal fistula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginal Fistula</mesh_term>
    <mesh_term>Vesicovaginal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

